GlaxoSmithKline CR`s ROE reached 4.30 % in 2017. This is 61.7 % more than in the previous year.
Buy ROE data for GlaxoSmithKline Czech Republic.
$19.99Buy all data for GlaxoSmithKline Czech Republic.
Buy annual subscriptions for all our products.
| Company | Unit | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 |
| Amgen Czech Republic | % | ... | ... | ... | ... | ... | 31.6 | 15.4 | 15.8 | 21.7 | 18.4 | ||||||||
| Bayer Czech Republic | % | ... | ... | ... | 34.8 | 22.3 | 33.5 | 40.5 | 50.6 | ||||||||||
| GlaxoSmithKline Czech Republic | % | ... | ... | ... | 19.3 | 12.0 | 9.41 | 6.64 | 9.44 | ||||||||||
| Merck Czech Republic | % | ... | ... | 24.6 | 24.7 | 9.05 | 10.5 | 17.8 | |||||||||||
| Novartis Czech Republic | % | 19.2 | 18.9 | 16.5 | 21.6 | 17.8 | |||||||||||||
| Pfizer Czech Republic | % | ... | ... | 25.2 | 4.63 | 11.1 | 8.21 | 5.24 | |||||||||||
| Roche Czech Republic | % | ... | ... | ... | 4.85 | 3.57 | 11.5 | 8.00 | 4.40 | ... | |||||||||
| Sanofi-Aventis Czech Republic | % | ... | ... | ... | ... | 11.0 | 8.21 | 10.8 | 0.186 | 8.76 | |||||||||
| Servier Czech Republic | % | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | 38.6 | 33.9 | 25.4 | 23.4 | ||
| Walmark | % | ... | ... | ... | 18.8 | -0.377 | -1.71 | 6.40 | -246 |
Helgi Library 
